Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Ruesselsheim Am Main

7 clinical trials in Ruesselsheim Am Main, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Ruesselsheim Am Main at a glance
7
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Ruesselsheim Am Main

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1
  • Sponsor:Sanofi Pasteur Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Ruesselsheim Am Main

What the registry says about research in the country

01 Orthopedic Surgery & Thromboprophylaxis

Innovative research exploring enhanced recovery protocols in hip arthroplasty patients, focusing on optimized anticoagulation strategies for preventing post-surgical complications.

  • Total Hip Arthroplasty (THA)
  • Venous Thromboembolism Prevention
  • Enhanced Recovery After Surgery (ERAS)

Studies evaluate shortened anticoagulation duration while maintaining patient safety and recovery outcomes.

02 Early-Stage Breast Cancer

Groundbreaking research investigating extended endocrine therapy options for patients with ER-positive/HER2-negative early breast cancer.

  • Extended Adjuvant Therapy
  • Recurrence Prevention
  • Hormone Receptor-Positive Disease

Novel therapeutic approaches aim to improve long-term outcomes after standard treatment completion.

03 Advanced Breast Cancer

Comprehensive analysis of treatment patterns in advanced breast cancer, focusing on innovative therapeutic strategies for hormone receptor-positive disease.

  • First-line Treatment
  • Survival Outcomes
  • Treatment Response Patterns

Research aims to understand efficacy and resistance patterns in advanced disease settings.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.